1. Investigations in the pathogenesis and treatment of pulmonary diseases associated with alcohol use disorders
2. Superimposed respiratory effects of tobacco and cannabis utilization in patients with AUDs
3. Mechanisms defined in healthy participants with AUDs will be further explored in cohorts of critically ill patients to determine their impact on clinical outcomes and to tailer therapy.

Researchers would:

1. Receive access to clinical and translational research support in the area of alcohol misuse
2. Receive access to a Biorepository of human participants’ specimens and data, including patients with COVID-19
3. Be able to focus on respiratory-or pulmonary-related diseases, with a consideration for investigations in other organ systems
4. Be able to conduct exploratory investigations related to other substances commonly consumed with alcohol, including tobacco and cannabis

1. Click HERE to discover who distributes and directs CoPARC data and samples, the requirements for receiving data and samples, and the prioritization of data and sample distribution.
2. Fill out our Sample and Data Request Form  AND email it to our CoPARC Director and ourBiorepository Manager along with an updated Biosketch of the principal investigator(s).
3. Discuss your project's unique needs with CoPARC resource personnel.
4. Your project will be reviewed by the CoPARC steering committee.
5. The CoPARC team will work with you to provide data, biospecimens, and other needed information in a timely manner (including support for IRB or contracting that may be required.

Interested in learning more about various pulmonary-related research topics?

• View CoPARC's upcoming seminars in the upcoming events tab of our website